Literature DB >> 21680950

Topographical continuity of bacterial populations in the healthy human respiratory tract.

Emily S Charlson1, Kyle Bittinger, Andrew R Haas, Ayannah S Fitzgerald, Ian Frank, Anjana Yadav, Frederic D Bushman, Ronald G Collman.   

Abstract

RATIONALE: Defining the biogeography of bacterial populations in human body habitats is a high priority for understanding microbial-host relationships in health and disease. The healthy lung was traditionally considered sterile, but this notion has been challenged by emerging molecular approaches that enable comprehensive examination of microbial communities. However, studies of the lung are challenging due to difficulties in working with low biomass samples.
OBJECTIVES: Our goal was to use molecular methods to define the bacterial microbiota present in the lungs of healthy individuals and assess its relationship to upper airway populations.
METHODS: We sampled respiratory flora intensively at multiple sites in six healthy individuals. The upper tract was sampled by oral wash and oro-/nasopharyngeal swabs. Two bronchoscopes were used to collect samples up to the glottis, followed by serial bronchoalveolar lavage and lower airway protected brush. Bacterial abundance and composition were analyzed by 16S rDNA Q-PCR and deep sequencing.
MEASUREMENTS AND MAIN RESULTS: Bacterial communities from the lung displayed composition indistinguishable from the upper airways, but were 2 to 4 logs lower in biomass. Lung-specific sequences were rare and not shared among individuals. There was no unique lung microbiome.
CONCLUSIONS: In contrast to other organ systems, the respiratory tract harbors a homogenous microbiota that decreases in biomass from upper to lower tract. The healthy lung does not contain a consistent distinct microbiome, but instead contains low levels of bacterial sequences largely indistinguishable from upper respiratory flora. These findings establish baseline data for healthy subjects and sampling approaches for sequence-based analysis of diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680950      PMCID: PMC3208663          DOI: 10.1164/rccm.201104-0655OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

Review 1.  New technologies, human-microbe interactions, and the search for previously unrecognized pathogens.

Authors:  David A Relman
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

3.  Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia.

Authors:  A Ortqvist; M Kalin; L Lejdeborn; B Lundberg
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

4.  Quantitative bacterial cultures of bronchoalveolar lavage fluids.

Authors:  J A Pang; A F Cheng; H S Chan; G L French
Journal:  Am Rev Respir Dis       Date:  1989-09

5.  Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.

Authors:  B Souweine; B Veber; J P Bedos; B Gachot; M C Dombret; B Regnier; M Wolff
Journal:  Crit Care Med       Date:  1998-02       Impact factor: 7.598

6.  Estimating the population size for capture-recapture data with unequal catchability.

Authors:  A Chao
Journal:  Biometrics       Date:  1987-12       Impact factor: 2.571

7.  Quantitative aspiration during sleep in normal subjects.

Authors:  K Gleeson; D F Eggli; S L Maxwell
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

8.  Pharyngeal aspiration in normal adults and patients with depressed consciousness.

Authors:  E J Huxley; J Viroslav; W R Gray; A K Pierce
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

9.  A pilot study of quantitative aspiration in patients with symptoms of obstructive sleep apnea: comparison to a historic control group.

Authors:  Michael Beal; Andrew Chesson; Thomas Garcia; Gloria Caldito; Fred Stucker; Cherie-Ann Nathan
Journal:  Laryngoscope       Date:  2004-06       Impact factor: 3.325

10.  Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia.

Authors:  D E Cantral; T G Tape; E C Reed; J R Spurzem; S I Rennard; A B Thompson
Journal:  Am J Med       Date:  1993-12       Impact factor: 4.965

View more
  455 in total

1.  Abnormal epithelial structure and chronic lung inflammation after repair of chlorine-induced airway injury.

Authors:  Yiqun Mo; Jing Chen; David M Humphrey; Ramy A Fodah; Jonathan M Warawa; Gary W Hoyle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

Review 2.  Update in respiratory infections 2011.

Authors:  Richard G Wunderink; Michael S Niederman
Journal:  Am J Respir Crit Care Med       Date:  2012-06-15       Impact factor: 21.405

Review 3.  Homeostasis and its disruption in the lung microbiome.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

Review 4.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 5.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

Review 6.  The Landscape Ecology and Microbiota of the Human Nose, Mouth, and Throat.

Authors:  Diana M Proctor; David A Relman
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

7.  Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.

Authors:  Leopoldo N Segal; Jose C Clemente; Jun-Chieh J Tsay; Sergei B Koralov; Brian C Keller; Benjamin G Wu; Yonghua Li; Nan Shen; Elodie Ghedin; Alison Morris; Phillip Diaz; Laurence Huang; William R Wikoff; Carles Ubeda; Alejandro Artacho; William N Rom; Daniel H Sterman; Ronald G Collman; Martin J Blaser; Michael D Weiden
Journal:  Nat Microbiol       Date:  2016-04-04       Impact factor: 17.745

8.  Comparison of the respiratory microbiome in healthy nonsmokers and smokers.

Authors:  Alison Morris; James M Beck; Patrick D Schloss; Thomas B Campbell; Kristina Crothers; Jeffrey L Curtis; Sonia C Flores; Andrew P Fontenot; Elodie Ghedin; Laurence Huang; Kathleen Jablonski; Eric Kleerup; Susan V Lynch; Erica Sodergren; Homer Twigg; Vincent B Young; Christine M Bassis; Arvind Venkataraman; Thomas M Schmidt; George M Weinstock
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

9.  FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.

Authors:  Elliot S Friedman; Yun Li; Ting-Chin David Shen; Jack Jiang; Lillian Chau; Luciano Adorini; Farah Babakhani; Jeffrey Edwards; David Shapiro; Chunyu Zhao; Rotonya M Carr; Kyle Bittinger; Hongzhe Li; Gary D Wu
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

10.  Development of a Stable Lung Microbiome in Healthy Neonatal Mice.

Authors:  Matea Kostric; Katrin Milger; Susanne Krauss-Etschmann; Marion Engel; Gisle Vestergaard; Michael Schloter; Anne Schöler
Journal:  Microb Ecol       Date:  2017-09-13       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.